Key Takeaways
- • Prosper AI raised $30 million in Series A funding led by Andreessen Horowitz, with participation from Base10, Emergence Capital, Y Combinator, and Company Ventures, validating the market for AI-driven healthcare administrative automation.
- • The platform automates end-to-end patient journey workflows including appointment scheduling, insurance verification, patient billing, and insurer communication via voice, API, fax, and browser-based interfaces integrated directly into electronic health records (EHRs).
- • Since its seed funding announcement nine months prior, Prosper AI achieved 5x revenue growth and expanded its customer base to over 40 healthcare organizations, demonstrating rapid commercial traction in a fragmented healthcare operations market.
- • Co-founder and co-CEO Xavier de Gracia outlined an ambitious three-to-five-year vision where AI workforce agents become permanent layers within healthcare operations, complementing human staff across pre-visit and post-visit care coordination workflows.
- • DLA Piper served as legal counsel to lead investor Andreessen Horowitz on the transaction, signaling institutional-grade due diligence and governance standards typical of mid-stage healthcare technology investments.
Summary
Prosper AI, a healthcare administration automation startup, secured $30 million in Series A funding led by venture capital firm Andreessen Horowitz. The round included participation from Base10 Partners, alongside continued backing from earlier investors Emergence Capital, Y Combinator, and Company Ventures. The financing announcement comes nine months after the company's seed funding round and reflects accelerating momentum in the AI-driven healthcare operations automation sector.
The company operates an agentic AI platform designed to automate administrative workflows across the full patient journey. Unlike point-solution competitors that address specific tasks such as scheduling or billing in isolation, Prosper AI's system orchestrates multiple functions: answering inbound patient calls, scheduling appointments directly within electronic health record systems, verifying insurance benefits in real time, automating patient billing cycles, and contacting insurers via phone to request missing information. The platform operates across multiple channels—voice, APIs, fax, and browser-based automation for accessing insurance company portals—positioning it as a comprehensive operational layer rather than a single-use tool.
According to co-CEO Xavier de Gracia, the company's strategic vision extends beyond current voice capabilities toward building what he terms "an AI workforce for healthcare operations teams." De Gracia articulated a three-to-five-year thesis wherein large patient groups and health systems will deploy persistent AI agents alongside human staff, integrated as native layers within EHR infrastructure. This positioning suggests Prosper AI is pursuing deep integration partnerships with major EHR vendors and health system operators, rather than remaining a standalone third-party application.
The company's commercial performance supports investor confidence in this vision. Since its prior funding announcement, Prosper AI reported 5x revenue growth and added more than 40 healthcare organizations as customers. This rapid customer expansion, coupled with demonstrated revenue scaling, indicates meaningful product-market fit within healthcare administrative operations—an area historically characterized by fragmentation, manual processes, and acute labor shortages.
DLA Piper provided legal counsel to Andreessen Horowitz on the transaction, reflecting the institutional governance standards typical of Series A healthcare technology financings at this stage and valuation level.
The company operates an agentic AI platform designed to automate administrative workflows across the full patient journey. Unlike point-solution competitors that address specific tasks such as scheduling or billing in isolation, Prosper AI's system orchestrates multiple functions: answering inbound patient calls, scheduling appointments directly within electronic health record systems, verifying insurance benefits in real time, automating patient billing cycles, and contacting insurers via phone to request missing information. The platform operates across multiple channels—voice, APIs, fax, and browser-based automation for accessing insurance company portals—positioning it as a comprehensive operational layer rather than a single-use tool.
According to co-CEO Xavier de Gracia, the company's strategic vision extends beyond current voice capabilities toward building what he terms "an AI workforce for healthcare operations teams." De Gracia articulated a three-to-five-year thesis wherein large patient groups and health systems will deploy persistent AI agents alongside human staff, integrated as native layers within EHR infrastructure. This positioning suggests Prosper AI is pursuing deep integration partnerships with major EHR vendors and health system operators, rather than remaining a standalone third-party application.
The company's commercial performance supports investor confidence in this vision. Since its prior funding announcement, Prosper AI reported 5x revenue growth and added more than 40 healthcare organizations as customers. This rapid customer expansion, coupled with demonstrated revenue scaling, indicates meaningful product-market fit within healthcare administrative operations—an area historically characterized by fragmentation, manual processes, and acute labor shortages.
DLA Piper provided legal counsel to Andreessen Horowitz on the transaction, reflecting the institutional governance standards typical of Series A healthcare technology financings at this stage and valuation level.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.